Skip to main content
. 2021 Apr 30;12(5):428. doi: 10.1038/s41419-021-03628-5

Fig. 2. ADAMTS9 attenuated malignant phenotypes in AGS and BGC-823 cells.

Fig. 2

A ADAMTS9 expression levels were examined by reverse transcriptase PCR assay; B and western blotting assay. C Expression levels of ADAMTS9 in AGS and BGC-823 cells transfected with ADAMTS9 overexpression plasmid and empty plasmid were analyzed by reverse transcriptase PCR and western blotting assay. D ADAMTS9 inhibits the cell growth in AGS and BGC-823 cells. E ADAMTS9 suppresses the colony formation in AGS and BGC-823 cells. F ADAMTS9 inhibited growth of tumors in vivo. Tumor growth curves and tumor weight shows the suppressive effect of ADAMTS9 in vivo. G ADAMTS9 impairs motile capacity in AGS and BGC-823 cells detected by wound healing assay (magnification 40×); H and by transwell assay (magnification 100×).